MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Philips to acquire BioTelemetry for $2.47B

Philips to acquire BioTelemetry for $2.47B

By

Royal Philips (NYSE:PHG) announced today that it agreed to acquire BioTelemetry (NSDQ:BEAT) in a deal worth $2.8 billion.

Amsterdam-based Philips is slated to commence a tender offer to acquire all issued and outstanding shares of BioTelemetry for $72 per share, to be paid upon completion. That represents a 16.5% premium to BioTelemetry’s closing price on Dec. 17, 2020, bringing the value of the acquisition to $2.8 billion, inclusive of BioTelemetry’s cash and debt, according to a news release.

BioTelemetry’s board of directors has approved the transaction and recommends the offer to its shareholders, leading to expectations that the merger will be completed in the first quarter of 2021.

Philips expects to supplement its in-hospital patient monitoring business with BioTelemetry’s cardiac diagnostics and monitoring technologies for outside the hospital, leading the newly merged companies to become a leader for patient care management solutions for the hospital and the home for cardiac and other patients.

“The acquisition of BioTelemetry fits perfectly with our strategy to be a leading provider of patient care management solutions for the hospital and the home,” Philips CEO Frans van Houten said in the release. “BioTelemetry’s leadership in the large and fast-growing ambulatory cardiac diagnostics and monitoring market complements our leading position in the hospital. Leveraging our collective expertise, we will be in an optimal position to improve patient care across care settings for multiple diseases and medical conditions.”

BioTelemetry develops diagnostics and monitors for heart rhythm disorders, including wearable heart monitors that detect and transmit abnormal heart rhythms wirelessly, along with AI-based data analytics and services.

“Through continued innovation, we have developed the world’s largest remote cardiac monitoring services network,” BioTelemetry president & CEO Joseph H. Capper said. “We are delighted to become part of Philips and continue on our journey to deliver health information to improve the quality of life and reduce the cost of care. Combined with Philips’ current patient care management portfolio, innovation strength and global scale, we are perfectly equipped to address the rising demand for telehealth and remote monitoring solutions.”

Upon the completion of the transaction, BioTelemetry and its approximately 1,900 employees will join Philips’ connected care business segment.

Philips anticipates that the acquisition will be sales growth and EBITA margin accretive in 2021, with the BioTelemetry slated to grow double-digits and improve the company’s adjusted EBITA margin to more than 20% by 2025.

In case you missed it

RSS From Medical Design & Outsourcing

  • Smith+Nephew makes a play in remote physical therapy
    The British medtech giant seeks to tap digital health to fuel growth in orthopedics. The Aria Home PT remote physical therapy device is the latest example. It’s the size of a small flatscreen TV and shows up at someone’s house before they undergo knee or hip surgery at an ambulatory surgery center, interacting with them… […]
  • AdvaMed wants feds to give medical supply chain priority
    Medtech trade group AdvaMed wants the Biden administration to put the transport of medical supplies at the top of its list to address supply chain problems at ports worldwide. On his first day in office, Biden issued an executive order that promised, in part, to secure the pandemic supply chain and create a U.S. manufacturing… […]
  • The cultural shift to smart manufacturing for medical devices
    Medical device manufacturers are experiencing unprecedented challenges. With the global pandemic negatively impacting markets, they are under pressure to produce increasingly complex products, quicker and at lower cost. To remain competitive in this marketplace, manufacturers must move towards smart manufacturing to increase innovation and enhance processes. To take significant, actionable steps in manufacturing and production… […]
  • DeviceTalks eyeing 2022 return to Boston, Minneapolis, Santa Clara
    For the past 15 months, DeviceTalks has connected tens of thousands of medical professionals through a growing series of podcasts and virtual meetings. Now, we’re pleased to announce we’ll be resuming our in-person meetings in 2022. DeviceTalks will hold meetings in three of the country’s medical device hubs – Boston, Minneapolis and Silicon Valley. Each… […]
  • GS Plastic Optics boasts reduced turn-around times
    GS Plastic Optics (Rochester, N.Y.) is touting how it has reduced lead times for its single-point diamond turning point operations. The result, according to GS Plastic Optics, is that it is now capable of turn-around times as little as 4–6 weeks depending on material availability and design complexity. The company achieved reduced lead times through… […]
  • Onkos Surgical wins FDA clearance for BioGrip 3D-printed implant
    Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology. The Parsippany, N.J.–based company designed BioGrip to address the clinical challenge of aseptic loosening in musculoskeletal oncology and complex orthopedic limb salvage surgery. It helps provide bone ingrowth at the bone-implant interface. The 3D-printed porous structure, nano HA treated… […]
  • Supreme Court rejects Medtronic bid to overturn spine surgeon’s royalties win
    Medtronic (NYSE:MDT) lost its bid Monday to have the U.S. Supreme Court toss a decision awarding $112 million in royalties to an Indiana spine surgeon-turned-inventor. The court declined to hear a petition by Medtronic to overturn an appeals court decision that allowed the jury’s award to Dr. Rick Sasso to stand. Sasso won the royalties decision… […]
  • Avania acquires medtech contract research organization IMARC
    Avania today said it has acquired medical device clinical research outfit IMARC for an undisclosed amount. Strongsville, Ohio–based IMARC is a full-service clinical research oversight company that offers monitoring, auditing, safety, data management and training. “At Avania, we are focused on building a high-quality, full-service specialist medical technology CRO with global reach,” Avania CEO Sapna… […]
  • How to choose the right printing technology for UDI codes
    UDI labeling can identify medical devices through their distribution and use. The deadline for labeling Class 1 and unclassified devices is coming up. Tim Kearns, Videojet Technologies Whether you are expanding the production of medical devices already subject to Unique Device Identification (UDI) requirements or finishing your plan to meet the FDA’s UDI requirements for… […]
  • 3 Minnesota medtech execs make EY entrepreneur finalist list
    A trio of Minnesota medtech business leaders has landed on the finalist list for EY Entrepreneur of the Year 2021 Heartland. Executives from AbiliTech Medical, Minnesota Rubber & Plastics and TSI rank among the 36 finalists from Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota and South Dakota. The finalists were selected by a panel of… […]
  • U.S. Supreme Court kicks Arthrex case back to patent board
    The U.S. Supreme Court ruled today that Patent Trial and Appeal Board judges are unconstitutionally appointed, but that greater supervision by the PTAB director would solve the problem. The opinion in the case followed a 2019 appeals court ruling in the closely watched patent spat between Arthrex and Smith+Nephew (NYSE:SNN). In the original lawsuit, Smith+Nephew and ArthroCare (which Smith+Nephew acquired… […]